Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational studyRosa Ruchlemer, Tamar Lachish, Ronen Ben‐Ami et al.|Mycoses|2019Cited by 80
Characteristics and recognition of early infections in patients treated with commercial anti‐CD19 CAR‐T cellsOfrat Beyar‐Katz, Ron Ram, Ronit Gold et al.|European Journal Of Haematology|2021Cited by 41
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL CellsYamit Shorer Arbel, Yair Herishanu|Frontiers in Oncology|2021Cited by 15